Celsion Corporation $3.18

down -0.02


20/8/2014 11:31 AM  |  NASDAQ : CLSN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get CLSN Trend Analysis - it has outperformed the S&P 500 by 171%

Partner Headlines

  1. Morning Market Movers

    Benzinga
  2. Benzinga's M&A Chatter for Tuesday June 10, 2014

    Benzinga
  3. Celsion to Present Updated Overall Survival Results from HEAT Study of ...

    Benzinga
  4. Celsion Says Recent Analysis Indicates ThermoDox Could Significantly Improve ...

    Benzinga
  5. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving ...

    Benzinga
  6. Celsion Announces $15M At-The-Market Registered Direct Offering

    Benzinga
  7. Morning Market Movers

    Benzinga
  8. Celsion Presents Combined Clinical Data from Two Phase I Trials

    Benzinga
  9. Celsion Announces Zhejiang HISUN Pharmaceutical does Not Plan to Pursue ...

    Benzinga
  10. Stocks Hitting 52-Week Lows

    Benzinga
  11. Celsion Halted Wednesday, Says Will Host Conference Call Jan 31

    Benzinga
  12. Option Speculators Circle Celsion

    SchaeffersResearch
  13. Stocks Hitting 52-Week Highs

    Benzinga
  14. UPDATE: Dawson James Initiates Celsion at Market Outperform on Phase III ...

    Benzinga
  15. Celsion Corp Says Continuing Phase 2 Study

    Benzinga
  16. Celsion Corporation (CLSN) CEO Michael H Tardugno buys 5,000 Shares

    GuruFocus
  17. Celsion Thermodox Gets Orphan Drug Status in US/Europe

    Benzinga
  18. Health Care Sector Wrap

    FoxBusiness
  19. Gap, General Motors Among Stocks Up on High Volume Friday

    FoxBusiness
  20. Call Volume Surges as Celsion Extends Its Rally

    SchaeffersResearch
  21. Celsion Announces Collaboration With the University of Oxford for First ...

    Benzinga
  22. Celsion Announces Resubmission With Philips Healthcare of Combined IND/IDE ...

    Benzinga
  23. Celsion Announces ThermoDox Commercial Supply Agreement With Hisun

    Benzinga
  24. Rodman & Renshaw Maintains Outperform on Celsion

    Benzinga
  25. Celsion Completes Consultative Review Process With EMA for Phase III HEAT ...

    Benzinga
  26. Celsion Corp. (CLSN) CEO Michael H Tardugno buys 5,000 Shares

    GuruFocus
  27. Celsion Corp. (CLSN) CFO Gregory L Weaver buys 5,000 Shares

    GuruFocus
Trading Center